Concepedia

Mohammed Alradhi

MA

Statistics

Publications

5

Citations

59

H-Index

5

Active since

2021

Affiliations

First Affiliated Hospital of Dalian Medical University(Current)

Dalian Medical University

Second Affiliated Hospital of Dalian Medical University

Qingdao Binhai University

Second Hospital of Shandong University

Mohammed Alradhi is an author at First Affiliated Hospital of Dalian Medical University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2021–2022

5

Publications

5

Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study

Abdullah Al-Danakh, Mohammed Safi, Mohammed Alradhi et al. · Cells · 2022 · 13 citations · Full text

, , +17

Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma

Salem Baldi, Hassan Khamgan, Yuanyuan Qian et al. · Frontiers in Oncology · 2021 · 12 citations · Full text

, , +17

<scp>ARID1A</scp> downregulation promotes cell proliferation and migration of colon cancer via <scp>VIM</scp> activation and <scp>CDH1</scp> suppression

Salem Baldi, Qianshi Zhang, Zhenyu Zhang et al. · Journal of Cellular and Molecular Medicine · 2022 · 12 citations · Full text

, , +17

Can bipolar transurethral enucleation of the prostate be a better alternative to the bipolar transurethral resection of the prostate?

Mohammed Alradhi, Lo Ka Lun, Mohammed Safi et al. · Medicine · 2021 · 11 citations · Full text

, , +11

Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study

Mohammed Alradhi, Mohammed Safi, Shenghua Tao et al. · Therapeutic Advances in Urology · 2022 · 11 citations · Full text

, , +13

1–5 of 5